Salbutamol 100mcg Inhaler
You will answer clinical questions before treatment is considered. Submitting a consultation does not guarantee supply.
Salbutamol 100mcg Inhaler is an inhaled treatment used for asthma where clinically appropriate. It contains Salbutamol 100 micrograms.
Salbutamol is a rapid-acting bronchodilator used to relieve acute wheeze, chest tightness and breathlessness. For common 100 microgram inhalers, the usual starting dose for symptoms is one inhalation, increased to two if necessary.
Suitability depends on your symptoms, medical history, current medicines, allergies, previous treatment and pregnancy or breastfeeding considerations where relevant.
How to use
Use Salbutamol 100mcg Inhaler exactly as directed by your pharmacist, prescriber or the patient information leaflet supplied with the product.
The treatment schedule for asthma is: 1 to 2 puffs when required. Do not change the dose, frequency or duration unless advised by a clinician.
Use the exact inhaler device and strength prescribed and check your inhaler technique. If the inhaler contains a corticosteroid, rinse the mouth with water after the maintenance dose and spit it out.
Current UK asthma guidance does not recommend SABA-only treatment for people aged 12 and over with confirmed asthma. Increasing or frequent reliever use should trigger review of asthma control and anti-inflammatory treatment rather than automatic repeat supply.
If symptoms of asthma worsen, do not respond as expected or you develop a serious reaction, stop and seek appropriate clinical advice.
Main Ingredients
Salbutamol 100mcg Inhaler contains Salbutamol 100 micrograms as the main active ingredient or treatment component.
The exact formulation, excipients, device components or inactive ingredients can vary by manufacturer and pack supplied.
Always check the patient information leaflet or product instructions supplied with your specific pack, particularly if you have known allergies or intolerances.
Side Effects & Cautions
Tremor, headache, palpitations and a fast heartbeat can occur. Increasing reliance on a reliever inhaler or poor symptom control requires asthma review.
Current UK asthma guidance does not recommend SABA-only treatment for people aged 12 and over with confirmed asthma. Increasing or frequent reliever use should trigger review of asthma control and anti-inflammatory treatment rather than automatic repeat supply.
This service is not for a new asthma diagnosis or an acute asthma attack. Severe breathlessness, difficulty speaking, exhaustion, drowsiness or inadequate response to reliever treatment requires urgent medical help.
Stop treatment and seek urgent medical help for difficulty breathing, swelling of the face, lips or tongue, collapse or another severe allergic reaction.
Suitability is confirmed through clinical assessment. Prescription medicine is supplied only where clinically appropriate.
Read the official patient information leaflet before using any medicine. The leaflet provides important information on use, cautions, side effects and storage.
Open leaflet on eMC